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The importance of H2S in biology and medicine has been widely recognized in recent years, and protein
S-sulfhydration is proposed to mediate the direct actions of H2S bioactivity in the body. Thioredoxin 1
(Trx1) is an important reducing enzyme that cleaves disulﬁdes in proteins and acts as an S-denitrosylase.
The regulation of Trx1 on protein S-sulfhydration is unclear. Here we showed that Trx1 facilitates protein
S-desulfhydration. Overexpression of Trx1 attenuated the basal level and H2S-induced protein S-sulf-
hydration by direct interaction with S-sulfhydrated proteins, i.e., glyceraldehyde 3-phosphate dehy-
drogenase and pyruvate carboxylase. In contrast, knockdown of Trx1 mRNA expression by short inter-
fering RNA or blockage of Trx1 redox activity with PX12 or 2,4-dinitrochlorobenzene enhanced protein S-
sulfhydration. Mutation of cysteine-32 but not cysteine-35 in the Trp–Cys32–Gly–Pro–Cys35 motif
eliminated the binding of Trx1 with S-sulfhydrated proteins and abolished the S-desulfhydrating effect of
Trx1. All these data suggest that Trx1 acts as an S-desulfhydrase.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Hydrogen sulﬁde (H2S) can S-sulfhydrate proteins by yielding a
hydropersulﬁde moiety (–SSH) in the active cysteine residues [1–
3]. It is predicted that S-sulfhydration can alter protein con-
formation and the ﬁnal function and activity of target proteins
[2,4]. This particular redox modiﬁcation of cysteine by S-sulfhy-
dration has been achieved using proteomics techniques by cou-
pling a speciﬁc enrichment strategy (biotin-switch assay and/or
tag-switch assay) with high-throughput mass spectrometry ana-
lysis [1,5,6]. So far, there have been a dozen proteins observed to
be modiﬁed by H2S through S-sulfhydration. KATP channel is a
direct target for H2S in regulating vasodilation and cardioprotec-
tion [7]. In fact, H2S induces S-sulfhydration of Kir6.1 subunit of
KATP channels, and dithiothreitol reverses this S-sulfhydration [4].
H2S-induced S-sulfhydration of phosphatase PTP1B alters en-
doplasmic reticulum stress response [8]. H2S S-sulfhydrates p65
and mediates the anti-apoptotic effect of NF-κB [6]. H2S modulates
cellular redox signaling via direct S-sulfhydration of Keap1/Nrf2B.V. This is an open access article u
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nt., Canada P3E 2C6.system, p66, and electrophiles, contributing to the beneﬁcial ef-
fects of H2S on cellular aging and heart failure [9–11]. S-sulfhy-
dration of MEK1 leads to PARP1 activation and induces DNA da-
mage repair in endothelia cells [12]. More recently, we observed
that S-sulfhydration of IRF-1 and pyruvate carboxylase induce
mitochondrial DNA replication and gluconeogenesis [13,14].
Like protein phosphorylation and S-nitrosylation, S-sulfhydra-
tion is proposed to mediate or modulate transduction of myriad
cellular signals [1–3]. While decades of research have established
the generality and broad physiological importance of protein
phosphorylation and S-nitrosylation, our current understanding of
the fundamental biology and chemistry of S-sulfhydration as a
protein signaling modality is still in its infancy [15,16]. Is H2S S-
sulfhydration of cysteine enzyme-regulated or a spontaneous
process? How is the biochemical stability of S-sulfhydrated pro-
teins? Which critical factors are involved and what conditions are
required for the formation of S-sulfhydration? Is there any possi-
bility for desulfhydration and/or transsulfhydration and how are
they regulated? Little is known about the nature of or even ne-
cessity for enzymatic mechanisms that may directly add or remove
SH groups from cysteine thiols.
In the present study, we demonstrated that thioredoxin 1
(Trx1), an oxidoreductase found in both prokaryotes and eu-
karyotes, is essential for protein S-desulfhydration. Overexpression
of Trx1 attenuated the basal level and H2S-induced protein S-
sulfhydration by direct interaction with S-sulfhydrated proteins,
i.e., glyceraldehyde 3-phosphate dehydrogenase (GAPDH) andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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strengthened protein S-sulfhydration. Furthermore, mutation of
cyseine-32 in Trx1 eliminated the binding of Trx1 with S-sulfhy-
dated proteins and abolished the S-desulfhydrating effect of Trx1
on both GAPDH and PC.2. Materials and methods
2.1. Cell culture and transfection
HepG2 (a human hepatocellular liver carcinoma cell line) and
HEK293 cells were purchased from American Type Culture Col-
lection (Manassas, VA) and maintained in Dulbecco's Modiﬁed
Eagle's medium (Sigma, Oakville, ON) supplemented with 10%
fetal bovine serum (Clontech, Mountain View, CA) and 1% peni-
cillin–streptomycin solution (Sigma). For cell transfection, wild-
type Trx1 or mutant Trx1 was transfected into HEK293 or HepG2
cells using Lipofectamine™ 2000 reagent as described by the
manufacturer's protocol (Invitrogen, Burlington, ON). Pre-designed
Trx1-targeted short interfering RNA (Trx1-siRNA) was purchased
from Ambion (Austin, TX). Negative siRNA (Neg-siRNA), a 21-nu-
cleotide RNA duplex with no known sequence homology with all
the genes, was also from Ambion. Transfection of siRNA into
HEK293 cells was achieved using the siPORTTM lipid transfection
agent from Ambion as we previously described [10].
2.2. Construction of Trx1 mutants
The plasmid Myc-TRX was purchased from Addgene (MA, USA)
[17]. Single mutation of cyteine-32 (Trx1-C32) and cysteine-35
(Trx1-C35) to serine were conducted using the Quick Change Site-
Directed Mutagenesis kit (Stratagene, CA, USA) [12]. The oligonu-
cleotides using for mutagenesis were 5′- CTTCTCAGCCACGTG-
GAGTGGGCCTTGCAAAATG-3′ (forward) and 5′-CATTTTGCAAGG-
CCCACTCCACGTGGCTGAGAAG-3′ (reverse) for cysteine-32, and 5′-
CGTGGTGTGGGCC-TAGCAAAATGATCAAGC-3′ (forward) and 5′-
GCTTGATCATTTTGCTAGGCCCACACCACG-3′ for cysteine-35. The
correct mutant was conﬁrmed by DNA sequencing at the Paleo-
DNA laboratory in Lakehead University, ON, Canada.
2.3. Western immunoblotting
The cells were harvested and lysed in a cell lysis buffer in-
cluding protease inhibitor cocktail (Sigma). Extracts were sepa-
rated by centrifugation at 14,000g for 15 min at 4 °C. SDS-PAGE
and Western blot analysis were performed. Brieﬂy, equal amount
of proteins were boiled in 1 SDS sample buffer and run in a 10%
SDS-PAGE gel, and transferred onto pure nitrocellulose blotting
membranes (Pall Corporation). The membrane was blocked with
3% nonfat dry milk solution in PBS at room temperature for 2 h
and rinsed three times with PBS before incubating with primary
antibodies. After that, the immunoblots were probed with anti-
biotin (1:500 dilution; Santa Cruz Biotechnology), anti-Trx1 (1:500
dilution; Santa Cruz Biotechnology), anti-PC (1:500 dilution; Santa
Cruz Biotechnology) and horseradish peroxidase (HRP)-conjugated
rabbit anti-mouse secondary antibody (1:10,000 dilution; Sigma).
Anti-GAPDH primary antibody (1:10,000 dilution; Sigma) and
HRP-conjugated rabbit anti-mouse secondary antibody (1:5,000
dilution; Sigma) were employed to normalize protein expression
after the membranes were stripped by incubating in a buffer
containing 100 mM β-mercaptoethanol, 2% SDS, and 62.5 mM
Tris–HCl (pH 6.8). The blots were developed using chemilumi-
nescence (ECL Western Blotting Detection Reagents, Amersham
Biosciences).2.4. Biotin switch assay of S-sulfhydration
Biotin switch assay was carried-out as described previously
with some modiﬁcations [1,10]. Brieﬂy, the cells were homo-
genized in HEN buffer (250 mM HEPES (pH 7.7), 1 mM EDTA, and
0.1 mM Neocuproine) supplemented with 100 μM deferoxamine
and centrifuged at 13,000 g for 30 min at 4 °C. The lysates were
added to blocking buffer (HEN buffer adjust to 2.5% SDS and
20 mM methyl methanethiosulfonate (MMTS)) at 50 °C for 20 min
with frequent vortexing. The MMTS was then removed by acetone
and the proteins were precipitated at 20 °C for 20 min. Proteins
were resuspended in HENS buffer (HEN buffer containing 1% SDS)
and 4 mM biotin-N-[6-(biotinamido) hexyl]-3′-(2′-pyridyldithio)
propinamide (HPDP) in DMSO without ascorbic acid. After in-
cubation for 2 h at 25 °C, biotinylated proteins were puriﬁed by
streptavidin–agarose beads, which were then washed with HENS
buffer. The biotinylated proteins were eluted by SDS-PAGE sample
buffer and subjected to Western blotting analysis with antibody
against biotin, GAPDH or PC. For quantitation of protein S-sulfhy-
dration, samples were run on blots alongside the same amount of
lysates (total protein) without processing biotin switch assay and
then subjected to western blotting by using the same antibody.
The ratio of S-sulfhydrated protein signal to total protein signal
was then densitometrically analyzed using the software Image J.
2.5. Co-Immunoprecipitation (Co-IP)
The cells were lysed in IP lysis/wash buffer (25 mM Tris, 0.15 M
NaCl, 1 mM EDTA, 1% NP-40, 5% glycerol, pH 7.4) including pro-
tease inhibitor cocktail (Sigma) [10]. The proteins (500 mg) were
then incubated with 5 μg anti-PC antibody (Santa Cruz Bio-
technology, Santa Cruz, CA) or anti-GAPDH (Santa Cruz Bio-
technology) for overnight at 4 °C. Protein A/G agarose was in-
cubated with lysates for 1 h with gentle end-over-end mixing.
Agarose resin was washed three times with IP lysis/wash buffer.
The resin was then washed one time with saline solution (0.15 M
NaCl). Immune complex was eluted with 2 SDS PAGE sample
buffer (62.5 mM Tris–Cl, pH 6.8, 2% SDS, 10% glycerol, 50 mM DTT,
and 0.01% bromophenol blue) at 100 °C for 5 min. The samples
were subjected to Western immunoblotting analysis.
2.6. Statistical analysis
Data were presented as means7SEM, representing at least
three independent experiments. Statistical comparisons were
made using Excel 2007 (Microsoft, Redmond, WA) with Student's
t-test to evaluate the difference between two groups, and the
difference between multiple groups were analyzed by using Sig-
maPlot 12.0 (Systat Software Inc. San Jose, CA) with ANOVA and
post-hoc Tukey test. Signiﬁcance level was set at po0.05.3. Results
3.1. Trx1 suppresses protein S-sulfhydration
Protein S-sulfhydration can be detected by the modiﬁed biotin
switch assay [1]. Following the procedures descried in the Meth-
ods, the S-sulfhydrated thiols were labeled with biotin–HPDP and
then detected by western blotting with the antibody against either
biotin or speciﬁc protein. We ﬁrst detected the basal labeling of
global proteins using an antibody against biotin, and the signaling
became even stronger after treatment with 50 mM NaHS (a well-
known H2S donor) for 2 hours in HEK293 cells. We further found
that Trx1 overexpression in HEK293 cells markedly decreases
H2S-induced protein S-sulfhydration (Fig. 1A). Probing with
Fig. 1. Trx1 acts as an S-desulfhydrase. A, B, and C, Trx1 overexpression inhibited the S-sulfhydration level of global proteins, PC and GAPDH in HEK293 cells. HEK293 cells
were transfected with Trx1 cDNA for 24 h, and then treated with 50 mM NaHS for 2 h. After that, the cells were collected for biotin switch assay using antibody against biotin
(A), PC (B), and GAPDH (C). *po0.05 versus all other groups. n¼4. D and E, Trx1 overexpression inhibited PC and GAPDH S-sulfhydration in HepG2 cells. HepG2 cells were
transfected with Trx1 cDNA for 24 h, and then treated with 50 mM NaHS for 2 h. After that, the cells were collected for biotin switch assay using antibody against PC (D) and
GAPDH (E). *po0.05 versus all other groups. n¼4.
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(Fig. 1C), it clearly showed that both GAPDH and PC proteins were
basically S-sulfhydrated and further strengthened by exogenously
applied NaHS, while transfection of HEK293 cells with Trx1 cDNA
signiﬁcantly reversed the basal and H2S-initiated S-sulfhydration
of PC and GAPDH, suggesting Trx1 acts as an S-desulfhydrase.
Identical results were further validated in another cell line, HepG2
cells (Fig. 1D and E). Trx1 cDNA alone slightly inhibited the basal
level of protein S-sulfhydration.
3.2. Inhibition of Trx1 activity stimulates protein S-sulfhydration
PX12, an irreversible and competitive inhibitor of Trx1, signiﬁcantlyenhanced the S-sulfhydration of PC and GAPDH when compared with
the control HepG2 cells (Fig. 2A and B). Similarly, 2,4-dinitro-
chlorobenzene (DNCB), an irreversible inhibitor of thioredoxin re-
ductase (TrxR), also increased S-sulfhydrated PC and GAPDH (Fig. 2C
and D), suggesting that thioredoxin reductase cooperates with Trx1
contributing to protein S-desulfhydration. Either PX12 or DNCB did not
further increase H2S-stimulated PC and GAPDH S-sulfhydration
(Fig. 2A–D). And next we tried to knockdown Trx1 in HEK293 cells by
siRNA transfection. Compared with the negative siRNA-transfected
cells, the basal level of PC and GAPDH S-sulhydration were sig-
niﬁcantly increased (Fig. 2E and F). Furthermore, we observed that
PX12 or DNCB signiﬁcantly reverses the inhibitory role of Trx1 over-
expression on S-desulfhydration of PC and GAPDH (Fig. 3A–D).
Fig. 2. Inhibition of Trx system enhances protein S-sulfhydration. A and B, PX12 induces PC and GAPDH S-sulfhydration. HepG2 cells were ﬁrstly treated with 5 mM PX12 for
4 h, and then 50 mM NaHS was added for additional 2 h. After that, the cells were collected for biotin switch assay using antibody against PC (A) and GAPDH (B). *po0.05
versus control. n¼4. C and D, DNCB induces PC and GAPDH S-sulfhydration. HepG2 cells were treated with 40 mM DNCB or 30 min and/or 50 mM NaHS for 2 h. After that, the
cells were collected for biotin switch assay using antibody against PC (C) and GAPDH (D). *po0.05 versus control. n¼4. E and F, knockdown of Trx1 stimulates PC and
GAPDH S-sulfhydration. HEK293 cells were transfected with Trx1-speciﬁc siRNA or negative siRNA for 48 h following incubation with 50 mMNaHS for 2 h. After that, the cells
were collected for biotin switch assay using antibody against PC (E) and GAPDH (F). *po0.05 versus control. n¼3.
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Fig. 3. PX12 and DNCB reverse the inhibitory effect of Trx1 on protein S-desulfhydration. A and B, PX12 abolished the inhibitory effect of Trx1 on PC and GAPDH S-
desulfhydration. HEK293 cells were ﬁrstly transfected with Trx1 cDNA for 24 h following incubation with 5 mM PX12 for 4 h and/or 50 mM NaHS for 2 h. After that, the cells
were collected for biotin switch assay using antibody against biotin PC (A) and GAPDH (B). *po0.05 versus control. n¼4. C and D, DNCB reversed the inhibitory effect of Trx1
on PC and GAPDH S-desulfhydration. HEK293 cells were ﬁrstly transfected with Trx1 cDNA for 24 h following incubation with 40 mM DNCB or 30 min and/or 50 mM NaHS for
2 h. After that, the cells were collected for biotin switch assay using antibody against biotin PC (C) and GAPDH (D). *po0.05 versus control. n¼4.
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Fig. 4. Cysteine-32 in Trx1 is responsible for Trx1 S-desulfhydrating proteins. A and B, cysteine-32 mutation abolished the inhibitory role of Trx1 on protein S-desulfhy-
dration. HEK293 cells were transfected with Trx1 cDNA and mutated Trx1 cDNA (C32S and C35S) for 24 h following incubation with 50 mM NaHS for 2 h. After that, the cells
were collected for biotin switch assay using antibody against PC (A) and GAPDH (B). *o0.05 versus the control without NaHS treatment. n¼4. C and D, cysteine-32 mutation
disassociated Trx1 binding with S-sulfhydrated PC and GAPDH. HEK293 cells were transfected with Trx1 cDNA and mutated Trx1 cDNA (C32S and C35S) for 24 h following
incubation with 50 mM NaHS for 2 h. After that, the cells were collected for co-immunoprecipitation assay as indicated in the ﬁgure. n¼3.
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Trx1 has a highly conserved active site, Trp–Cys32–Gly–Pro–Cys35,
which is required for its redox activity [18,19]. Here we found that
mutation of cysteine-32 but not cysteine-35 in the
Trp-Cys32–Gly–Pro–Cys35 motif eliminates the S-desulfhydration ac-
tivity of Trx1 on both PC and GAPDH (Fig. 4A and B), suggesting cy-
steine-32 is requisite for Trx1 S-desulfhydration of proteins. Trx1 di-
rectly interacted with PC and GAPDH, which was not altered in the
presence of NaHS. Interestedly, mutation of cysteine-32 but not cy-
steine-35 abolished the binding of Trx1 with PC (Fig. 4C) or GAPDH
(Fig. 4B).4. Discussion
H2S regulates cellular processes largely through S-sulfhydration
of active cysteine residues within proteins [2,3]. S-sulfhydration of
proteins has been demonstrated to be involved in a broad range of
signaling and metabolic pathways, including cell death and dif-
ferentiation, enzymatic activity, protein localization, protein–pro-
tein interactions, and protein stability, etc [1,4,6,8,10–12,20,21].
Given the importance of protein S-sulfhdyration in both healthand diseases, much less is known about the systems governing
protein S-desulfhydration. In our present report, we demonstrated
that Trx1 is essential for breakage of hydropersulﬁde group from
the cysteine thiol in S-sulfhdyrated proteins by direct interaction
with Trx1 at cysteine-32.
Trx1, a ubiquitous 12 kDa proteins with general anti-oxidative
properties, is involved in a large number of cellular functions such
as cell proliferation and differentiation, redox and metabolic
pathways, gene transcription, embryogenesis, etc [22–26]. In re-
cent years, Trx1 has been suggested to mediate cysteine S-deni-
trosylation by reducing inter- and intramolecular disulﬁde bonds
in proteins [26,27]. By analogy to S-nitrosylation, the extent of S-
sulfhydration of a given protein must be governed by the equili-
brium between S-sulfhydration and S-desulfhydration reactions
[26]. Protein S-sulfhydration is mainly dependent on the activity of
H2S-producing enzymes [6,28]. Here we showed that Trx1 is
clearly involved in protein S-desulfhydration, because over-
expression of Trx1 suppressed but blockage of Trx1 activity en-
hanced protein S-sulfhydration. Trx1 catalyzes thiol-disulﬁde oxi-
doreductions by using redox-active cysteine residues present in a
Trp–Cys32–Gly–Pro–Cys35 sequence motif [25,27,29]. The active
cysteine residues form a disulﬁde in oxidized Trx1, while the
disulﬁde is broken into reduced Trx1 with the aid of TrxR using
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activity by DNCB must block the transition of reduced Trx1 to
oxidized Trx1, which diminishes the inhibitory role of Trx1 on
protein S-desulfhydration. These ﬁndings indicate that protein S-
desulfhydration is indeed mediated by the Trx1/TrxR system.
We further provided evidence that Trx1 contributes to protein
S-desulfhydration via protein-to-protein association between its
substrate and Trx1 at cysteine-32. Co-immunoprecipitation results
demonstrated that Trx1 directly interacts with S-sulfhydrated
proteins, and single mutation of cysteine-32 to serine abolished
the inhibitory role of Trx1 on protein S-desulfhydration. Mutation
of cysteine-32 also eliminated the binding of Trx1 with S-sulfhy-
drated proteins. In contrary, mutation of cysteine-35 in the same
Trp–Cys32–Gly–Pro–Cys35 sequence motif failed to change the S-
desulfhydration activity of Trx1. There may be several reasons for
this difference. Firstly, formation of the cysteine-32/cystine-35
disulﬁde bridge leads to a rotation of the side-chain of cysteine-32
away from cysteine-35 in the reduced form [19,24]. Mutation of
cysteine-32 will induce formation of new disulﬁde between cy-
steine-35 and other cysteine residues within Trx1, which would
change the position of cysteine 32 and block the interaction of
cysteine-32 with S-sulfhydrated proteins. Secondly, the thiol of
cysteine-32 has a low pKa value in comparison with cysteine-35,
and cysteine-32 is more easily attacked by S-sulfhydrated proteins
for disulﬁde reduction [25,29,30]. Thirdly, Trx-interacting protein
(Txnip), a constitutively expressed protein, forms a mixed disulﬁde
with the active site cysteine-32 of Trx1 [18,26,31]. Mutation of
cysteine-32 would interrupt the interaction of Txnip with Trx1,
thereby affecting the oxidoreductase activity of Trx1. More studies
are required to elucidate the precise interaction of Trx1 cysteine-
32 and S-sulfhydrated proteins. In addition, we cannot exclude the
possibility that other cysteine residues within Trx1 are involved in
this process.
Two major pathways for enzymatic denitrosylation have re-
cently been recognized [24]. Besides with Trx system, S-ni-
trosoglutathione (GSNO) reductase also can lower the levels of
protein S-nitrosothiols [19,26,32]. Unlike Trx1, which directly tar-
get speciﬁc S-nitrosylated proteins for cysteine reduction, GSNO
reductase indirectly decreases cell protein S-nitrosylation through
GSNO metabolism. In addition, glutathione, the most abundant
intracellular thiols, plays a major role in protein S-denitrosylation
by GSNO reductase. We had data showed that the supplemental of
glutathione has no effect on protein S-desulfhydration (data not
shown). Therefore, GSNO reductase would not act as an S-de-
sulfhydrase. The dynamic and regulation of protein S-sulfhydra-
tion/desulfhydration must be very complicated; many other fac-
tors may be also involved through non enzymatic processes, such
as extreme oxidative stress, energy depletion, and competition
with NO for the same cysteine residue(s), all of which need to be
further tested.
Based on the results above, we conclude that the S-desulfhy-
dration of proteins is associated with the Trx1/TrxR system, and
cysteine-32 within Trx1 is responsible for the direct interaction of
Trx1 and S-sulfhydrated proteins following the breakage of hy-
dropersulﬁde group. Further investigation on the role of Trx sys-
tem in relation to protein S-desulfhydation and their biological
relevance needs to be explored.Acknowledgment
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